Baumgart, S. J., Nevedomskaya, E., Lesche, R., Newman, R., Mumberg, D., & Haendler, B. (2020). Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation. Mol Oncol.
Chicago Style aipamenaBaumgart, Simon J., Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, and Bernard Haendler. "Darolutamide Antagonizes Androgen Signaling By Blocking Enhancer and Super‐enhancer Activation." Mol Oncol 2020.
MLA aipamenaBaumgart, Simon J., et al. "Darolutamide Antagonizes Androgen Signaling By Blocking Enhancer and Super‐enhancer Activation." Mol Oncol 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.